Trial Profile
The study for personnlized medicine using sorafenib with genome analysis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 May 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer; Renal cell carcinoma
- Focus Pharmacokinetics
- 04 May 2015 New trial record